Kube Pharmaceuticals Private Limited - Company Profile

It is a trading private limited company based in Nagpur, Maharashtra, India, established in 2017.
2017 Nagpur, Maharashtra, India Active
Last Updated:
About Kube Pharmaceuticals Private Limited

Kube Pharmaceuticals Private Limited, a active private limited company, was established on 22 February 2017 in Nagpur, Maharashtra, India. Engaging in wholesale within the trade sector, it holds CIN: U74999MH2017PTC291518. Registered under ROC Roc Nagpur. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nadir Ahsan Mushtaque Husain (Director), Abdul Rauf Shaikh (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H. No.141&142, Old Bhandara Road Shatranjipura, Nagpur, Maharashtra, 440008.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2017PTC291518

  • Registration Number

    291518

  • Incorporation Date

    22 February 2017

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Nagpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 9 Year, 18 Days
  • Last Filing with ROC 31 Mar 2025
Company report

Kube Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Kube Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Kube Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Nadir Ahsan Mushtaque Husain Director 22 Feb 2017 Current
Abdul Rauf Shaikh Director 22 Feb 2017 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Kube Pharmaceuticals.

Kube Pharmaceuticals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Kube Pharmaceuticals revenue growth over time
Kube Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Kube Pharmaceuticals?

In 2017, Kube Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Kube Pharmaceuticals?

Unlock and access historical data on people associated with Kube Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Kube Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kube Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Kube Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Kube Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Kube Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur. was recorded as a recent event.

  • Director Appointment

    Progress on Nadir Ahsan Mushtaque Husain was appointed as a Director was appointed as a Director on 22 Feb 2017 & has been associated with this company since 9 years 18 days . was documented.

  • Director Appointment

    Progress on Abdul Rauf Shaikh was appointed as a Director was appointed as a Director on 22 Feb 2017 & has been associated with this company since 9 years 18 days . was documented.

  • Company Incorporation

    Progress on Kube Pharmaceuticals Private Limited was registered on 22 Feb 2017 with Roc Nagpur & aged 9 years 18 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Kube Pharmaceuticals Private Limited?

The CIN of Kube Pharmaceuticals Private Limited is U74999MH2017PTC291518.

Where is Kube Pharmaceuticals Private Limited headquartered?

Kube Pharmaceuticals Private Limited is headquartered at H. No.141&142, Old Bhandara Road Shatranjipura, Nagpur, Maharashtra, 440008.

When was Kube Pharmaceuticals Private Limited incorporated?

Kube Pharmaceuticals Private Limited was incorporated on 22 February 2017.

Who are the current directors of Kube Pharmaceuticals Private Limited?

The current directors of Kube Pharmaceuticals Private Limited are

What is the primary industry of Kube Pharmaceuticals Private Limited?

The primary industry of Kube Pharmaceuticals Private Limited is Trade.

Is Kube Pharmaceuticals Private Limited a listed company?

Kube Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Kube Pharmaceuticals Private Limited?

The authorized capital of Kube Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Kube Pharmaceuticals Private Limited?

The compliance status of Kube Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available